Metastatic pancreatic cancer: abdominal pain in a 22-year-old woman

Abstract

Pancreatic cancer remains fourth among cancer-related deaths. Its diagnosis is often missed, owing to its vague abdominal symptoms, leading to a diagnosis of stage IV pancreatic cancer. FOLFIRINOX chemotherapy was administered to the patient in this report, resulting in significant improvement based on tests of biological markers as well as radiographic resolution of the metastatic disease. A keen awareness of this condition along with appropriate diagnostic tests can allow for an earlier diagnosis and may impact its high mortality.

Comparison of efficacy and safety of three different drugs combined with radiotherapy in the treatment of patients with advanced pancreatic cancer

“…With the increasing pressure of social life, the change of living habits and the influence of environmental changes, the incidence of pancreatic cancer is gradually increasing [1]. The clinical symptoms of pancreatic cancer are mostly upper abdomen fullness, lower back pain, Trop J Pharm Res, September 2022; 21 (9): 2018 weight loss and fatigue, which are not characteristic [2,3]. After patients are diagnosed, most of the cancer cells have metastasized to distant places, and about 80% of patients are in advanced stage [4].…”